Results of the survey at the CycloLab’s webinar on the pharmaceutical applications of cyclodextrins Day 1
During the webinar of CycloLab “Getting the best out of cyclodextrins” held on Apr.15-16, 2021, the participants could answer to
Category: Drug delivery
Central nervous system delivery of molecules across the blood-brain barrier
Therapies targeting neurological conditions such as Alzheimer’s or Parkinson’s diseases are hampered by the presence of the blood-brain barrier (BBB).
Statistics of the webinar on pharmaceutical applications of cyclodextrins
The webinar of CycloLab “Getting the best out of cyclodextrins” was held on Apr.15-16, 2021. Out of >500 registrations over
Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: characterization of electrospun- and lyophilized formulations
Veklury™ by Gilead Sciences, Inc., containing antiviral drug, remdesivir (REM) has received emergency authorization in the USA and in Europe
Visible Light-Activatable Cyclodextrin-Conjugates for the Efficient Delivery of Nitric Oxide with Fluorescent Reporter and their Inclusion Complexes with Betaxolol
Novel multifunctional drug delivery systems were developed by the Sortino’s group [1]. βCD-NBFNO1 and βCD-NBFNO2, covalently integrating an N-nitroso amino-nitro-benzofurazan
Evading Thermodynamic Constraints of Cyclodextrin-Drug Formulations
Drug Development and Delivery has published on excipients with the title: SPECIAL FEATURE – Excipients: Far From Inactive summarizing the
Cyclodextrins in Antiviral Therapeutics and Vaccines
The review of Braga et al. describes the various roles of cyclodextrins (CDs) in vaccines againstviruses and in antiviral therapeutics
FDA granted accelerated approval to umbralisib / HPBCD tablet
The Food and Drug Administration granted accelerated approval to umbralisib (Ukoniq, TG Therapeutics), a kinase inhibitor including PI3K-delta and casein
Reduced mortality rate and shorter time for clinical improvement upon Remdesivir treatment
This retrospective comparative effectiveness research study was conducted from March 4 to August 29, 2020, in a 5-hospital health system
Regorafenib@mannose-γ-cyclodextrin channel-type nanoparticles for colorectal cancer therapy
The malignancy of colorectal cancer is connected with inflammation and tumor-associated macrophages (TAMs), but effective therapeutics for colorectal cancer are